CHIMERIC THERAPEUTICS LIMITED — Director's Dealing 2023

Jul 16, 2023

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: Chimeric Therapeutics Limited (ASX:CHM) ABN: 68 638 835 828

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Mr Phillip Hains
Date of Appointment:	12 July 2023

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number	Class of Securities
Nil	Nil

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise to therelevant interest.	Number	Class of Securities
The CFO Solution Team Pty LtdSharedOfficeServicesPtyLtd	232,860142,8606,521,739	Fully Paid Ordinary SharesListed Options $0.255 Expiring 31March 2024Fully Paid Ordinary Shares

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder
(if issued securities)	N/A
No. and class of securities to
which interest relates	N/A

*issuance of these securities is subject to receipt of shareholder approval at the Company’s next shareholder meeting.

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002